InvestorsHub Logo
Followers 0
Posts 1
Boards Moderated 0
Alias Born 11/07/2018

Re: None

Wednesday, 11/07/2018 10:35:57 AM

Wednesday, November 07, 2018 10:35:57 AM

Post# of 486
Back on May 9, 2018, the CEO stated it would be 60-90 day extension to FDA submission of the De Novo process. However, once again we seem to be sitting here as investors with this CEO continuing to set expectations and fail to meet them.

I get that this process is long and difficult, and I am a patient person. However, in my experiences setting expectations with investors and the market over and over again, and missing those dates, or failing to update them continues to scare me.

Does anyone in this forum have a different perspective? It just seems that the communication is way to "positive" and fails to meet.